Health Condition 1: E611- Iron deficiency
Conditions
Interventions
Intervention1: Ferrous sulphate: Dose: 200mg, twice daily, oral route, duration: 8 weeks
Control Intervention1: Ferrous sulphate: Dose: 400mg, once daily on alternate days, oral route, duration: 8 wee
Sponsors
Viswanathan S
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient willing to give written informed consent and willing to come for follow-up 2. Adults 18-60 years of age of either sex 3. Patients newly diagnosed as mild to moderate iron deficiency anemia by WHO guidelines
Exclusion criteria
Exclusion criteria: 1. Patients having comorbidities like chronic kidney disease, chronic liver disease, severe anemia requiring blood transfusion/parenteral iron therapy, cardiac failure patients, gastrointestinal abnormalities, menstrual abnormalities, malignancies and HIV 2. Pregnant and Lactating mothers 3. Patients with clinical or laboratory evidence of other causes of anemia like hemolytic anemias, hemoglobinopathies, gastrointestinal bleed, iron malabsorption, megaloblastic anemia, or anemia of chronic disease 4. Patients with hypersensitivity and intolerance to oral iron supplements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy is assessed by increase in mean Hemoglobin and serum ferritin levels at the end of 4th week and 8th weeks respectively. Timepoint: 0,4,8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety is assessed by monitoring and recording adverse events reported by the patient at any time of the study. Timepoint: 4,8 weeks | — |
Countries
India
Contacts
Public ContactViswanathan S
Bangalore Medical College and Research Institute
Outcome results
None listed